Aaron Ondrey

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron Ondrey:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 134,642 $2,025,016 $15.04 11 Feb 2025 Direct
ROCKET PHARMACEUTICALS, INC. Chief Financial Officer Common Stock 128,173 $1,007,439 $7.86 03 Jul 2025 Direct
Mirati Therapeutics, Inc. Chief Financial Officer Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. Chief Financial Officer Option to Purchase Common Stock 0 23 Jan 2024 Direct

Insider Reports Filed by Aaron Ondrey

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCKT ROCKET PHARMACEUTICALS, INC. 03 Jul 2025 1 -$4,257 4 Chief Financial Officer 08 Jul 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 04 Apr 2025 1 -$39,647 4 Chief Financial Officer 08 Apr 2025, 16:06
RCKT ROCKET PHARMACEUTICALS, INC. 11 Feb 2025 2 $0 4 Chief Financial Officer 13 Feb 2025, 16:01
RCKT ROCKET PHARMACEUTICALS, INC. 01 Apr 2024 2 $0 4 Chief Financial Officer 03 Apr 2024, 18:02
RCKT ROCKET PHARMACEUTICALS, INC. 25 Mar 2024 0 $0 3 Chief Financial Officer 03 Apr 2024, 17:57
/report/000114036124003532-ondrey-aaron-2024-01-23 Mirati Therapeutics, Inc. 23 Jan 2024 6 $0 4 Chief Financial Officer 23 Jan 2024, 20:37
/report/000162828024000279-ondrey-aaron-2023-12-29 Mirati Therapeutics, Inc. 29 Dec 2023 1 +$999,984 4 CFO 03 Jan 2024, 17:55
/report/000162828023032107-ondrey-aaron-2023-09-08 Mirati Therapeutics, Inc. 08 Sep 2023 1 +$299,972 4 Interim CFO 12 Sep 2023, 18:30
/report/000162828023032105-ondrey-aaron-2023-09-08 Mirati Therapeutics, Inc. 08 Sep 2023 0 $0 3 Interim CFO 12 Sep 2023, 18:27